|
|||||
|
|
Hormone Therapy as a Protective Factor for Age-Related Macular Degeneration |
|
| Authors: | Jennifer L. Patnaik Anne M. Lynch Brandie D. Wagner E. Lacey Echalier Wendy M. Kohrt Marc T. Mathias |
| Affiliation: | 1. Department of Ophthalmology, University of Colorado School of Medicine , Aurora, CO, U.S.A Jennifer.Patnaik@cuanschutz.edu;3. Department of Ophthalmology, University of Colorado School of Medicine , Aurora, CO, U.S.A;4. Department of Ophthalmology, University of Colorado School of Medicine , Aurora, CO, U.S.A;5. Department of Biostatistics and Informatics, University of Colorado School of Public Health , Aurora, CO, U.S.A !["ORCID]({"type":"image","src":"/templates/jsp/images/orcid.png"} "\"ORCID") https://orcid.org/0000-0002-2745-0103;6. Division of Geriatric Medicine, University of Colorado School of Medicine , Aurora, CO, U.S.A |
| Abstract: | ABSTRACT PurposeThe purpose of this study was to determine if the use of menopausal hormone therapy (HT) is related to the development of neovascular (NV) age-related macular degeneration (AMD), geographic atrophy (GA) and/or early/intermediate AMD. |
| Keywords: | Age-related macular degeneration (AMD) menopausal hormone therapy (HT) hormone replacement therapy (HRt) ophthalmic epidemiology |